Cargando…

Epigenetic reprogramming enhances the therapeutic efficacy of osteoblast‐derived extracellular vesicles to promote human bone marrow stem cell osteogenic differentiation

Extracellular vesicles (EVs) are emerging in tissue engineering as promising acellular tools, circumventing many of the limitations associated with cell‐based therapies. Epigenetic regulation through histone deacetylase (HDAC) inhibition has been shown to increase differentiation capacity. Therefore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Man, Kenny, Brunet, Mathieu Y., Fernandez‐Rhodes, Maria, Williams, Soraya, Heaney, Liam M., Gethings, Lee A., Federici, Angelica, Davies, Owen G., Hoey, David, Cox, Sophie C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263905/ https://www.ncbi.nlm.nih.gov/pubmed/34262674 http://dx.doi.org/10.1002/jev2.12118

Ejemplares similares

An ECM-Mimetic Hydrogel to Promote the Therapeutic Efficacy of Osteoblast-Derived Extracellular Vesicles for Bone Regeneration
por: Man, Kenny, et al.
Publicado: (2022)

Development of a Bone-Mimetic 3D Printed Ti6Al4V Scaffold to Enhance Osteoblast-Derived Extracellular Vesicles’ Therapeutic Efficacy for Bone Regeneration
por: Man, Kenny, et al.
Publicado: (2021)

Controlled Release of Epigenetically-Enhanced Extracellular Vesicles from a GelMA/Nanoclay Composite Hydrogel to Promote Bone Repair
por: Man, Kenny, et al.
Publicado: (2022)

Epigenetic Reprogramming via Synergistic Hypomethylation and Hypoxia Enhances the Therapeutic Efficacy of Mesenchymal Stem Cell Extracellular Vesicles for Bone Repair
por: Man, Kenny, et al.
Publicado: (2023)

Osteoblast-Derived Vesicle Protein Content Is Temporally Regulated During Osteogenesis: Implications for Regenerative Therapies
por: Davies, Owen G., et al.
Publicado: (2019)

Corrigendum: Osteoblast-Derived Vesicle Protein Content Is Temporally Regulated During Osteogenesis: Implications for Regenerative Therapies
por: Davies, Owen G., et al.
Publicado: (2019)

Loss of β‐Actin Leads to Accelerated Mineralization and Dysregulation of Osteoblast‐Differentiation Genes during Osteogenic Reprogramming
por: Gjorgjieva, Tamara, et al.
Publicado: (2020)

Extracellular Vesicles Allow Epigenetic Mechanotransduction between Chondrocytes and Osteoblasts
por: Shang, Xiaobin, et al.
Publicado: (2021)

Physiological cyclic hydrostatic pressure induces osteogenic lineage commitment of human bone marrow stem cells: a systematic study
por: Stavenschi, Elena, et al.
Publicado: (2018)

Engineered Extracellular Vesicles: Tailored-Made Nanomaterials for Medical Applications
por: Man, Kenny, et al.
Publicado: (2020)

Osteogenic Response to Polysaccharide Nanogel Sheets of Human Fibroblasts After Conversion Into Functional Osteoblasts by Direct Phenotypic Cell Reprogramming
por: Nakai, Kei, et al.
Publicado: (2021)

Bioengineering extracellular vesicles: smart nanomaterials for bone regeneration
por: Man, Kenny, et al.
Publicado: (2023)

Para-Nonylphenol Impairs Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells by Influencing the Osteoblasts Mineralization
por: Abnosi, Mohammad Husein, et al.
Publicado: (2012)

Effect of Alumina Particles on the Osteogenic Ability of Osteoblasts
por: Sharma, Ashish Ranjan, et al.
Publicado: (2022)

Influence of Extracellular Vesicles Isolated From Osteoblasts of Patients With Cox-Arthrosis and/or Osteoporosis on Metabolism and Osteogenic Differentiation of BMSCs
por: Niedermair, Tanja, et al.
Publicado: (2020)

Dexamethasone in osteogenic medium strongly induces adipocyte differentiation of mouse bone marrow stromal cells and increases osteoblast differentiation
por: Ghali, Olfa, et al.
Publicado: (2015)

Comparison of the Anabolic Effects of Reported Osteogenic Compounds on Human Mesenchymal Progenitor-Derived Osteoblasts
por: Owen, Robert, et al.
Publicado: (2020)

Extracellular Vesicles Derived from Osteogenic-Differentiated Human Bone Marrow-Derived Mesenchymal Cells Rescue Osteogenic Ability of Bone Marrow-Derived Mesenchymal Cells Impaired by Hypoxia
por: Wang, Chenglong, et al.
Publicado: (2023)

Adipogenic RNAs are transferred in osteoblasts via bone marrow adipocytes-derived extracellular vesicles (EVs)
por: Martin, Perrine J, et al.
Publicado: (2015)

ASPN Synergizes with HAPLN1 to Inhibit the Osteogenic Differentiation of Bone Marrow Mesenchymal Stromal Cells and Extracellular Matrix Mineralization of Osteoblasts
por: Zhou, Guohui, et al.
Publicado: (2023)

Utilizing Osteocyte Derived Factors to Enhance Cell Viability and Osteogenic Matrix Deposition within IPN Hydrogels
por: Parmentier, Laurens, et al.
Publicado: (2020)

Bone tissue engineering using 3D silk scaffolds and human dental pulp stromal cells epigenetic reprogrammed with the selective histone deacetylase inhibitor MI192
por: Man, Kenny, et al.
Publicado: (2022)

Controlling Growth and Osteogenic Differentiation of Osteoblasts on Microgrooved Polystyrene Surfaces
por: Sun, Lanying, et al.
Publicado: (2016)

Effects of inactivated Enterococcus faecalis on the proliferation and osteogenic induction of osteoblasts
por: Tong, Zhongchun, et al.
Publicado: (2016)

Functionalization of Electrospun Polycaprolactone Scaffolds with Matrix-Binding Osteocyte-Derived Extracellular Vesicles Promotes Osteoblastic Differentiation and Mineralization
por: Nieuwoudt, Mechiel, et al.
Publicado: (2021)

Osteoblast-Secreted Factors Promote Proliferation and Osteogenic Differentiation of Bone Marrow Stromal Cells via VEGF/Heme-Oxygenase-1 Pathway
por: Zhang, Lian-Fang, et al.
Publicado: (2014)

Transcriptome Reprogramming of CD11b(+) Bone Marrow Cells by Pancreatic Cancer Extracellular Vesicles
por: Maia, Joana, et al.
Publicado: (2020)

Editorial: Extracellular Vesicle Treatment, Epigenetic Modification and Cell Reprogramming to Promote Bone and Cartilage Regeneration
por: Pei, Yixuan Amy, et al.
Publicado: (2021)

Epigenetic Control of Osteogenic Lineage Commitment
por: Montecino, Martin, et al.
Publicado: (2021)

Epigenetic Reprogramming and Emerging Epigenetic Therapies in CML
por: Bugler, Jane, et al.
Publicado: (2019)

Induction of Osteogenic Differentiation in Human Mesenchymal Stem Cells by Crosstalk with Osteoblasts
por: Glueck, Martina, et al.
Publicado: (2015)

Differentiated osteoblasts derived decellularized extracellular matrix to promote osteogenic differentiation
por: Jeon, Jin, et al.
Publicado: (2018)

The Pathogenic Effects of Fusobacterium nucleatum on the Proliferation, Osteogenic Differentiation, and Transcriptome of Osteoblasts
por: Gao, Hui, et al.
Publicado: (2020)

Focal adhesion regulates osteogenic differentiation of mesenchymal stem cells and osteoblasts
por: Zhao, Yang, et al.
Publicado: (2021)

Epigenetic reprogramming in the mammalian germline
por: Hsu, Fei-Man, et al.
Publicado: (2015)

Age reprogramming and epigenetic rejuvenation
por: Singh, Prim B., et al.
Publicado: (2018)

Cellular reprogramming and epigenetic rejuvenation
por: Simpson, Daniel J., et al.
Publicado: (2021)

Epigenetic Trajectories of Aging and Reprogramming
por: Niimi, Peter, et al.
Publicado: (2021)

Shared Genetic and Epigenetic Mechanisms between the Osteogenic Differentiation of Dental Pulp Stem Cells and Bone Marrow Stem Cells
por: Gaus, Sebastian, et al.
Publicado: (2021)

Bone Marrow Osteoblast Damage by Chemotherapeutic Agents
por: Rellick, Stephanie L., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_9ee68tr580794e89qelkq3ovd7